• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE SG; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE SG; IMPLANTABLE LEAD Back to Search Results
Model Number 0170
Medical Device Problem Codes High impedance (1291); Inappropriate/Inadequate Shock/Stimulation (1574); Defective Device (2588)
Health Effect - Clinical Codes Electric Shock (2554); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/30/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the lead was explanted as the lead conductor was visibly externalized.The externalized conductor was confirmed via fluoroscopy.The lead was replaced.No additional adverse patient effects were reported.
 
Event or Problem Description
It was reported that this implantable cardioverter defibrillator (icd) delivered inappropriately shock therapy to the patient.After analysis of the system it was noted that this icd recorded a code 1005 indicative an open circuit condition detected during shock delivery.Due to this the battery of the device reached battery capacity depletion.After review of the system, high out of range shock lead impedance measurements were observed on the right ventricular channel.The patient is planned for a procedure in the near future.This lead was replaced.During the explant procedure, it was noted that the lead conductor was visibly externalized.The externalized conductor was confirmed via fluoroscopy.No further adverse patient effects were reported.
 
Additional Manufacturer Narrative
Additional information was added to the following fields: bsc aware date.B5: describe event or problem field.H6: patient codes.H6: device codes.H6: impact codes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE SG
Common Device Name
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key15129157
Report Number2124215-2022-28153
Device Sequence Number5499212
Product Code LWS
UDI-Device Identifier00802526373282
UDI-Public00802526373282
Combination Product (Y/N)Y
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P910073/S041
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2011
Device Explanted Year2022
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date12/23/2012
Device Model Number0170
Device Catalogue Number0170
Device Lot Number100624
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 07/21/2022
Supplement Date Received by Manufacturer07/12/2022
Initial Report FDA Received Date07/29/2022
Supplement Report FDA Received Date08/03/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured12/23/2010
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age32 YR
Patient SexMale
-
-